Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma
- 1 November 1991
- Vol. 68 (9) , 1899-1902
- https://doi.org/10.1002/1097-0142(19911101)68:9<1899::aid-cncr2820680909>3.0.co;2-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatinCancer, 1990
- Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.Journal of Clinical Oncology, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.Journal of Clinical Oncology, 1984
- Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapyCancer, 1982
- Chemotherapy and thoractomy for metastatic osteogenic sarcoma.A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgeryCancer, 1978
- Preliminary results of aggressive multimodality therapy for metastatic osteosarcomaCancer, 1977
- Adjuvant multiple drug chemotherapy for osteosarcoma of the extremityCancer, 1977
- Adjuvant chemotherapy in primary treatment of osteogenic sarcoma.A southwest oncology group studyCancer, 1975
- The therapy of osteogenic sarcoma: Current status and thoughts for the futureJournal of Surgical Oncology, 1972